OCEANSIDE, New York. –November 7, 2007 –American Medical Alert Corp. (NASDAQ: AMAC) a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and nine months ended September 30, 2007, the highlights of which are as follows:

Revenues for the quarter ended September 30, 2007, consisting primarily of monthly recurring revenues (MRR), increased 13% to $8,771,670 as compared to $7,784,660 for the same period in 2006. Net income for the quarter ended September 30, 2007 increased 51% to $422,929 or $.04 per diluted share as compared to $279,421 or $.03 per diluted share for the same period in 2006.

Revenues for the nine months ended September 30, 2007 increased 16% to $26,373,312, as compared to $22,731,188 for the same period in 2006. Net income for the nine months ended September 30, 2007 increased 49% to $1,196,897 or $0.12 per diluted share as compared to a net income of $803,964 or $0.09 per diluted share for the previous year. Net Income for the trailing twelve months ended September 30, 2007 and 2006 was $1,655,462 and $1,031,219 respectively, representing an increase of 61%.

Earnings before interest, taxes and depreciation and amortization (“EBITDA”) for the nine months ended September 30, 2007 increased 31% to $5,612,802 as compared to $4,271,225 for the same period in 2006. EBITDA for the trailing twelve months ended September 30, 2007 and 2006 was $7,382,981 and $5,601,714 respectively, a 32% increase.

The Company affirms its guidance issued on July 26, 2007 that gross revenues, consisting primarily of monthly recurring revenue (MRR), will increase by 14% to $35,250,000 for 2007 while also projecting a 19% increase in earnings to $1,500,000 for the year ending December 31, 2007.

Jack Rhian, AMAC’s Chief Executive Officer and President, commented, “Of note this quarter, our TBCS division is in the final stage of securing relationships with several additional hospitals to utilize our specialized daytime business process augmentation services. This new business is expected to contribute significant growth to the division in 2008 and, more importantly, serves to affirm the potential scalability of this service offering.

Rhian continued, “Third quarter 2007 also marked the completion of the initial media campaign for the Walgreens Ready Response™ national rollout. The program has begun to contribute meaningfully to our subscriber base. We also determined a need for greater emphasis on in-store awareness and signage placement, which is being addressed by Walgreen. AMAC and Walgreen Co. management are currently evaluating the scope and terms of the 2008 marketing campaign. Throughout the remainder of the 4^th quarter, AMAC will continue to support select media placement based on the experience learned to date. We affirm our confidence in this business to consumer channel opportunity and believe this program has the potential to capture significant PERS subscriber market share in 2008.”

AMAC is a healthcare communications company dedicated to the provision of support services to the healthcare community. AMAC's product and service portfolio includes Personal Emergency Response Systems (PERS) and emergency response monitoring, electronic medication reminder devices, disease management monitoring appliances and healthcare communication solutions services. AMAC operates nine communication centers under local trade names: H-LINK OnCall, Long Island City, NY and Clovis, NM North Shore TAS, Port Jefferson, NY, Live Message America, Audubon, NJ, ACT Teleservice, Newington, CT and Springfield, MA, MD OnCall, Cranston RI, Capitol Medical Bureau Rockville, MD, American MediConnect and Phone Screen Chicago, IL to support the delivery of high quality, healthcare communications.

In addition to the results reported in accordance with accounting principles generally accepted in the United States (“GAAP”) included in this press release, the Company has provided information regarding certain non-GAAP financial measure. This measure is “earnings before interest, taxes and depreciation and amortization (“EBITDA”)”. Such information is reconciled to its closest GAAP measure in accordance with the Securities and Exchange Commission rules and is included in the attached supplemental data.

Management believes that the non-GAAP financial measure used in this press release is useful to both management and investors in their analysis of the Company’s financial position and results of operations. Management believes that EBITDA is a useful measure of the Company's financial performance as it is an indicator of the Company's ability to generate cash flow to make acquisitions, reinvest in new telehealth products and liquidate liabilities. Management also uses EBITDA for planning purposes to determine appropriate levels of operating and capital investments.

EBITDA is a non-GAAP financial measure and although management and some members of the investment community utilize it to measure financial performance, EBITDA should not be viewed as a substitute for financial data prepared in accordance with GAAP or as a measure of profitability. Additionally, the non-GAAP financial measure as presented by AMAC may not be comparable to similarly titled measures reported by other companies.

This press release contains forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements may be identified by the use of forward-looking terminology such as "may," "will," "expect," "believe," "estimate," "anticipate," "continue," or similar terms, variations of those terms or the negative of those terms. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K, the Company's Quarterly Reports on Forms 10-Q, and other filings and releases. These include uncertainties relating to government regulation, technological changes, our expansion plans, our contract with the City of New York and product liability risks.

	Three Months Ended				Nine Months Ended
	9/30/2007		9/30/2006		9/30/2007		9/30/2006

Revenues	$	8,771,670	$	7,784,660	$	26,373,312	$	22,731,188

Net Income	$	422,929	$	279,421	$	1,196,897	$	803,964

Net Income per Share
Basic	$	0.05	$	0.03	$	0.13	$	0.09
Diluted	$	0.04	$	0.03	$	0.12	$	0.09

Basic Weighted Average
Shares Outstanding		9,307,412		8,989,042		9,257,776		8,896,133

Diluted Weighted Average
Shares Outstanding		9,854,059		9,352,802		9,708,253		9,351,160

	June 30,		December 31,
	2007		2006
	(Unaudited)
ASSETS

Current Assets	$	9,420,588	$	7,651,185
Fixed Assets – Net		10,326,648		9,307,912
Other Assets		15,465,615		16,083,279

Total Assets	$	35,212,851	$	33,042,376

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current Liabilities	$	5,525,750	$	4,463,222
Deferred Income Tax		1,028,000		992,000
Long-term Debt		4,878,105		5,677,068
Long-term portion of capital lease		43,205		74,440
Other Liabilities		543,056		490,456

Total Liabilities	$	12,018,116	$	11,697,186

Stockholders’ Equity		23,194,735		21,345,190
Total Liabilities and Stockholders’ Equity	$	35,212,851	$	33,042,376

Add:

Less:

9/30/07

12/31/2006

Subtotal

9/30/2006

Total

Net Income

1,196,897

1,262,529

2,459,426

803,964

1,655,462

Add Backs:

Taxes

913,000

869,000

1,782,000

680,000

1,102,000

Interest

375,605

394,613

770,218

262,788

507,430

Depreciation & Amort.

3,127,300

3,515,262

6,642,562

2,524,473

4,118,089

EBITDA

5,612,802

7,382,981

Add:

Less:

9/30/06

12/31/2005

Subtotal

9/30/2005

Total

Net Income

803,964

932,436

1,736,400

705,181

1,031,219

Add Backs:

Taxes

680,000

866,000

1,546,000

651,000

895,000

Interest

262,788

52,638

315,426

32,695

282,731

Depreciation & Amort.

2,524,473

3,061,668

5,586,141

2,193,377

3,392,764

EBITDA

4,271,225

5,601,714